These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4024210)

  • 21. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
    Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
    Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of coumarin anticoagulants XXXV: Examination of possible pharmacokinetic interaction between (R)-(+)- and (S)-(--)-warfarin in humans.
    Levy G; O'Reilly RA; Wingard LB
    J Pharm Sci; 1978 Jun; 67(6):867-8. PubMed ID: 660478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates.
    McClellan SD; Farringer JA
    Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens.
    Pitsiu M; Parker EM; Aarons L; Rowland M
    Ther Drug Monit; 2003 Feb; 25(1):36-40. PubMed ID: 12548142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple technic for predicting daily maintenance dose of warfarin.
    Williams DB; Karl RC
    Am J Surg; 1979 Apr; 137(4):572-6. PubMed ID: 426209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic monitoring of warfarin: the appropriate response marker.
    Costa IM; Soares PJ; Afonso M; Ratado P; Lanaot JM; Falcão AC
    J Pharm Pharmacol; 2000 Nov; 52(11):1405-10. PubMed ID: 11186249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): a retrospective evaluation in an outpatient population.
    Gaulier JM; Boulieu R; Fischer C; Mauguiere F
    J Pharm Pharmacol; 1997 Jul; 49(7):734-6. PubMed ID: 9255721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimates of the population pharmacokinetic parameters and performance of Bayesian feedback: a sensitivity analysis.
    Vozeh S; Steiner C
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):511-28. PubMed ID: 3694495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
    Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
    Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin dosage predictions assisted by the analog computer.
    Carter BL; Barr W; Rock W; Taylor JW
    Ther Drug Monit; 1988; 10(1):69-73. PubMed ID: 3376184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of warfarin at steady state.
    Murray B; Coleman R; McWaters D; Ludden T; Mungall D
    Ther Drug Monit; 1987; 9(1):1-5. PubMed ID: 3576653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fat emulsion effects on prothrombin time in warfarin anticoagulated patients: an in vitro study.
    Cotto MA; Lutomski DM; Palascak JE; Fant WK; LaFrance RJ
    JPEN J Parenter Enteral Nutr; 1990; 14(2):201-3. PubMed ID: 2352338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacodynamic modeling and covariate detection for central neural blockade.
    Schnider TW; Minto CF; Bruckert H; Mandema JW
    Anesthesiology; 1996 Sep; 85(3):502-12. PubMed ID: 8853080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
    Godley PJ; Black JT; Frohna PA; Garrelts JC
    Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetics of coumarin anticoagulants XXXVI: Predicted steady-state patterns of prothrombin complex activity produced by equieffective doses of (R)-(+)- and (S)-(-)-warfarin in humans.
    Wingard LB; Levy G
    J Pharm Sci; 1977 Dec; 66(12):1790-1. PubMed ID: 925953
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of Bayesian predictability of vancomycin concentration in patients with various degrees of renal function.
    Ohnishi A; Yano Y; Shimamura K; Oguma T
    Biol Pharm Bull; 2001 Dec; 24(12):1446-50. PubMed ID: 11767122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictability of warfarin dose requirements: theoretical considerations.
    Sawyer WT
    J Pharm Sci; 1979 Apr; 68(4):432-4. PubMed ID: 438962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.